SCHEDULE 13G/AAccepted Aug 14, 4:01 PM ET
Avalo Therapeutics, Inc. SCHEDULE 13G/A
Accepted (ET)
4:01 PM
Aug 14, 2026
Filed
Aug 14, 2026
Documents
1
Size
25.3 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.